QA: Bioxytran INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001445815_2017_Bioxytran_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001445815, Bioxytran INC

  xvar xval
0 AssetsCurrent 26,964
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 24,707
3 remainder_Assets 0
4 LiabilitiesCurrent 342,266
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 821,470
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 96,777
11 remainder_Revenues 241,806
12 remainder_NetIncome -39,204
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 51,671
1 Liabilities 342,266
2 Expenses 918,247
3 Revenues 241,806
4 StockholdersEquity -290,595
5 NetIncome -715,645
6 ComprehensiveNetIncome -715,645
7 BaseVar 796,597
8 EconomicCapitalRatiobeforeLimitedLiability -6.85
9 EconomicCapitalRatio 0.0331

Edgar->Model Mapping

Feature Distribution

Change over Time